Cash for proof of concept
Tuesday, 11 November, 2008
A promising prostate cancer diagnostic test, bacteriophages to control salmonella in chickens and synthetic stretchy skin are the winners in a new round of proof-of-concept grants from the NSW Government.
Ten grants of up to $100,000 have been awarded to Sydney companies under the NSW Department of State and Regional Development’s BioBusiness proof-of-concept scheme.
Winners include Minomic, which is developing a proteomics-based urine test for prostate cancer; VetPhage, a company allied to Cellabs and Special Phage Services, which is developing bacteriophages for use in chickens bred for human consumption; and Elastagen, to produce a synthetic injectable form of tropoelastin for cosmetic and surgical applications.
Other winners include Human Genetic Signatures, which is developing a rapid diagnostic for MRSA; and Protech Research, which is developing enzyme technology to capture gluten lost in food processing.
Medical device companies NeuStent, Dosimetry and Imaging, E-Nose and Cellixe have also received grants.
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
